PDS Biotech Announces Retirement of Lauren V. Wood, M.D., an

PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer

Related Keywords

United States , Gina Cestari , Laurenv Wood , Frank Bedu , Kirk Shepard , Kirkv Shepard , University Of Cincinnati Medical School , Global Medical Affairs At Takeda Pharmaceuticals International , Department Of Hematology , Biotechnology Corporation The Company , Global Medical Affairs At Baxter International Inc , Exchange Commission , Scientific Affairs At Boehringer Ingelheim Pharmaceuticals Inc , Twitter , Biotechnology Corporation , Case Western Reserve University , Cornell University , Merck Co Inc , Affairs Professional Society , Cleveland Clinic Foundation , University Of Chicago Hospitals , United States Securities Exchange , Chief Medical Officer , Frank Bedu Addo , Chief Executive Officer , Senior Vice President , Global Medical Affairs Oncology Business Group , Eisai Pharmaceutical , Medical Affairs Professional Society , Global Medical Affairs , Baxter International Inc , Takeda Pharmaceuticals International , Vice President , Scientific Affairs , Boehringer Ingelheim Pharmaceuticals , Medical Oncology , Cincinnati Medical , Chicago Hospitals , Nasdaq Listing Rule , United States Securities Exchange Act , United States Securities Act , Financial Condition , Merck Sharp ,